These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9572055)

  • 1. The commercialization of human genetics: profits and problems.
    Caulfield T
    Mol Med Today; 1998 Apr; 4(4):148-50. PubMed ID: 9572055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withholding research results in academic life science. Evidence from a national survey of faculty.
    Blumenthal D; Campbell EG; Anderson MS; Causino N; Louis KS
    JAMA; 1997 Apr; 277(15):1224-8. PubMed ID: 9103347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On discovery, genomes, the Society, and society.
    Worton RG
    Am J Hum Genet; 2001 Apr; 68(4):819-25. PubMed ID: 11254439
    [No Abstract]   [Full Text] [Related]  

  • 5. The Human Genome Project: bibliography of ethical, social, legal, and scientific aspects.
    Arizona State University Center for the Study of Law, Science and Technology
    Jurimetrics; 1992; 32(2):223-311. PubMed ID: 11659418
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we patent God's creation?
    Peters T
    Dialog; 1996; 35(2):117-32. PubMed ID: 11660577
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical and legal issues in genetic epidemiology.
    Holtzman NA; Andrews LB
    Epidemiol Rev; 1997; 19(1):163-74. PubMed ID: 9360913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Commercialization of genetic research and its impact on the communication of results].
    Cardinal G
    Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting subjects' interests in genetics research.
    Merz JF; Magnus D; Cho MK; Caplan AL
    Am J Hum Genet; 2002 Apr; 70(4):965-71. PubMed ID: 11870592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.
    Natowicz MR; Ard C
    J Genet Couns; 1997 Sep; 6(3):337-55. PubMed ID: 11655206
    [No Abstract]   [Full Text] [Related]  

  • 11. Moving research to patient applications through commercialization: understanding and evaluating the role of intellectual property.
    Patino RM
    J Am Assoc Lab Anim Sci; 2010 Mar; 49(2):147-54. PubMed ID: 20353687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and the common good.
    Tauer CA
    Second Opin (Chic); 2001 Oct; (8):14-35. PubMed ID: 16025643
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues in genetic therapy.
    Penticuff J
    J Obstet Gynecol Neonatal Nurs; 1994; 23(6):498-501. PubMed ID: 7965255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who owns the genome?
    Angrist M; Cook-Deegan RM
    New Atlantis; 2006; 11():87-96. PubMed ID: 16789312
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics of prediction: genetic risk and the physician-patient relationship.
    Juengst ET
    Genome Sci Technol; 1995; 1(1):21-36. PubMed ID: 11660453
    [No Abstract]   [Full Text] [Related]  

  • 16. Disease gene patenting: the clinician's dilemma.
    Magnus D
    Camb Q Healthc Ethics; 1998; 7(4):433-5. PubMed ID: 9752586
    [No Abstract]   [Full Text] [Related]  

  • 17. The Human Genome Project and public perception: truth and consequences.
    Pelias MZ; Markward NJ
    Emory Law J; 2000; 49(3):837-58. PubMed ID: 12645564
    [No Abstract]   [Full Text] [Related]  

  • 18. A legal research agenda for the Human Genome Initiative.
    Karjala DS
    Jurimetrics; 1992; 32(2):121-222. PubMed ID: 11659417
    [No Abstract]   [Full Text] [Related]  

  • 19. Commercial backing 'could impair academic influence'.
    Wadman M
    Nature; 1996 Dec; 384(6609):501. PubMed ID: 8955258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.